Talks at the Square w. Justin Siegel

On December 6, we are thrilled to welcome Dr. Justin Siegel to BioInnovation Institute as he will host a ‘Talk at the Square’. During his talk, he will focus on how new technological advances driven by information technology and the biomedical sectors can be incorporated to the existing food system to create products that lead people to live happier, healthier and longer lives.

Dr. Siegel will use his own scientific research as a vantage point and provide several examples of how his work can contribute to solve some of the major challenges in modern society. Through his scientific work, he has focused on redesigning naturally occurring enzymes for the degradation of specific proteins, which for example could lead to better methods for C02 fixation – an important tool to decrease the overall green house gas emissions. Furthermore, he will touch upon how a deeper understanding of the relationship between protein sequence, structure and function has led to the creation of several start-ups in both the foodtech and the therapeutic space.

The event will also include a fireside chat with CEO of BioInnovation Institute, Jens Nielsen

Program of the day:

15.30 Doors open

16.00 Introduction to BII and the subject of the day: Jens Nielsen, CEO at BII

16.10 Keynote speaker: Justin Siegel 'Building the future of the food system'

16.40 Fireside chat with Jens Nielsen and questions

17.00 Informal networking and closing reception

Please note that the event has free admittance with 70 tickets available. Please sign up quickly to secure your seat.

If you have registered for the event but are unable to attend, please send an email to eto@bii.dk.

About Justin Siegel:

Dr. Siegel is an Associate Professor of Chemistry, Biochemistry & Molecular Medicine, at UC Davis in the Genome Center. He received his B.S. in Biochemistry from UC Davis in 2005 and his Ph.D. in Biomolecular Structure and Design from the University of Washington in 2011, after which he returned to UC Davis to begin his research lab. His scientific focus in the design and discovery of enzymes of interest to modern society. Through strong industrial and cross-disciplinary collaborations Dr. Siegel has engineered enzymes for a wide range of applications, including therapeutics development, natural product production, enhancing nutrient bioavailability, and fuel or chemical production. Dr. Siegel is co-inventor on >100 global patents and has >50 publications, as well as being a founding member of nine companies (Bio Architecture Labs, PvP Biologics, Digestiva, Peak B, New Syn, Vinzymes, PrismBio, Barnstorm Ventures, SFS Advisors), three international consortiums (Rosetta Commons Board, FoodShot Global, Innovation Institute for Food & Health), and two national consortiums (D2D Cure, AI Institute for Next Generation Food Systems).

About the Talks at the Square event series at BioInnovation Institute:

'Talks at the Square' is an event series by BioInnovation Institute (BII) with a key focus on spreading ideas and knowledge in life science entrepreneurship to inspire researchers to bring science out of the lab and into the economy. The events feature high-level international speakers with topics that emphasize innovations and inspirational topics within bioindustrials, health tech, and therapeutics. The Talks at the Square events are hosted by BioInnovation Institute at the Square event space at the BII facilities in Copenhagen Bio Science Park (COBIS) in Copenhagen. Read more on: https://bii.dk/events-and-news/